Higher prevalence of splenic artery aneurysms in hereditary hemorrhagic telangiectasia: Vascular implications and risk factors

Autoři: Jacques Sellier aff001;  Carma Karam aff001;  Alain Beauchet aff001;  Axel Dallongeville aff001;  Stephen Binsse aff001;  Sandra Blivet aff001;  Isabelle Bourgault-Villada aff001;  Philippe Charron aff002;  Thierry Chinet aff001;  Mélanie Eyries aff002;  Carole Fagnou aff001;  Jérome Lesniak aff001;  Gilles Lesur aff001;  Jérome Lucas aff001;  Agnès Nicod-Tran aff001;  Augustin Ozanne aff001;  Aurélien Palmyre aff002;  Florent Soubrier aff002;  Mostafa El Hajjam aff001;  Pascal Lacombe aff001
Působiště autorů: Ambroise Paré Hospital, AP-HP, Boulogne-Billancourt, University of Versailles-Saint Quentin en Yvelines, France aff001;  Pitié-Salpêtrière Hospital, Department of Genetics, AP-HP, Paris, France aff002
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
doi: 10.1371/journal.pone.0226681



Splenic artery aneurysm (SAA) is a rare but potentially fatal condition. Rupture results in 25% mortality up to 75% in pregnant women with 95% fetal mortality. Brief reports suggest an increased risk of developing SAA in patients with HHT.


We analyzed enhanced multidetector CT data in 186 HHT patients matched (gender and ± 5 year old) with 186 controls. We screened for SAA and recorded diameter of splenic and hepatic arteries and hepatic, pancreatic and splenic parenchymal involvements. We determined by univariate and multivariate analysis, the relationship with age, sex, genetic status, cardiovascular risk factors (CVRF) and visceral involvement.


SAA concerned 24.7% of HHT patients and 5.4% of controls, p<0.001. Factors associated with increased risk of SAA in HHT were female gender (p = 0.04, OR = 2.12, IC 95% = 1.03–4.50), age (p = 0.0003, OR = 1.04, 95% CI = 1.02–1.06) and pancreatic parenchymal involvement (p = 0.04, OR = 2.13, 95% CI = 1.01–4.49), but not type of mutation, hepatic or splenic parenchymal involvements, splenic size or splenic artery diameter or CVRF.


We found a 4.57 higher rate of SAA in HHT patients without evidence of splenic high output related disease or increased CVRF. These results suggest the presence of a vascular intrinsic involvement. It should lead to screening all HHT patients for SAA. The vasculopathy hypothesis could require a change in management as screening of all systemic arteries and even the aorta and to further research in the field.

Klíčová slova:

Aneurysms – Arteries – Blood flow – Cardiovascular diseases – Computed axial tomography – Hypertensive disorders in pregnancy – Medical risk factors – Pregnancy


1. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91(1):65–67.

2. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD et al.HHT Foundation International—Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011; 48(2):73–87. doi: 10.1136/jmg.2009.069013 19553198

3. Arthur H, Geisthoff U, Gossage JR, Hughes CC, Lacombe P, Meek ME, et al. Executive summary of the 11th HHT international conference. Angiogenesis 2015; 18(4): 511–524. doi: 10.1007/s10456-015-9482-5 26391603

4. Moulinet T, Mohamed S, Deibener-Kaminsky J, Jankowski R, Kaminsky P. High prevalence of arterial aneurysms in hereditary hemorrhagic telangiectasia. Int J Cardiol 2014;176(3):1414–1416. doi: 10.1016/j.ijcard.2014.08.016 25150474

5. Bensalah M, El Hajjam M, Sellier J, Binsse S, Chinet T, Roume J, et al. Multidetector contrast-enhanced computed tomography in the evaluation of splenic involvement in patients with hereditary hemorrhagic telangiectasia: a prospective study. Hematology Reports 2013; 5 (s1):6–7. Abstract: Oral Communication. 10th HHT Scientific Conference. 2013. Cork, Ireland.

6. Caillouette J.C., Merchant E.B. Ruptured splenic artery aneurysm in pregnancy. Twelfth reported case with maternal and fetal survival. Am J Obstet Gynecol, 168 (1993), pp. 1810–1811[discussion 1811–3] doi: 10.1016/0002-9378(93)90694-e 8317525

7. Garcia-Tsao G. Liver involvement in hereditary hemorrhagic telangiectasia (HHT). J Hepatol 2007; 46(3):499–507. doi: 10.1016/j.jhep.2006.12.008 17239481

8. Lacout A, Pelage JP, Lesur G, Chinet T, Beauchet A, Roume J, et al. Pancreatic involvement in hereditary hemorrhagic telangiectasia: assessment with multidetector helical CT 1. Radiology 2010; 254(2): 479–484. doi: 10.1148/radiol.09090096 20093519

9. Beaussier M. Sur un aneurisme de l’artère splénique dont les parois se sont ossifiées. J Med Clin Pharm 1770.

10. Stanley JC, Wakefield TW, Graham LM, Whitehouse WM Jr, Zelenock GB, Lindenauer SM. Clinical importance and management of splanchnic artery aneurysms. J Vasc Surg 1986; 3(5), 836–840. 3701947

11. Bedford PD, Lodge B. Aneurysm of the splenic artery. Gut 1960; 1: 312–320. doi: 10.1136/gut.1.4.312 13688586

12. Moore SW, Guida PM, Schumacher HW. Splenic artery aneurysm. Bull Soc Int Chir 1970; 29(4): 210–218. 5483639

13. Schuster NH. Familial haemorrhagic telangiectasia associated with multiple aneurysms of the splenic artery. J Pathol Bacteriol 1937; 44: 29–39.

14. Halpern M, Turner AF, Citron BP. Hereditary Hemorrhagic Telangiectasia: an angiographic study of abdominal visceral angiodysplasias associated with gastrointestinal hemorrhage. Radiology 1968; 90(6): 1143–1149. doi: 10.1148/90.6.1143 5656734

15. Lande A, Bedford A, Schechter LS. The spectrum of arteriographic findings in Osler-Weber-Rendu diease. Angiology 1976; 27(4):223–240. doi: 10.1177/000331977602700404 1053528

16. Delvi MB, Khan-Ghori S, Al-Salman MMS, Takrouri MSM. Osler-Weber-Rendu disease. Unexpected complication following excision of splenic aneurysm. A case report. Middle East J Anaesthesiol 2004; 17(6): 1135–1142. 15651520

17. Al-Habbal Y, Christophi C, Muralidharan V. Aneurysms of the splenic artery–A review. The Surgeon 2010; 8(4): 223–231. doi: 10.1016/j.surge.2009.11.011 20569943

18. Maillard M, Novellas S, Baudin G, Benzaken T, Karimdjee B, Anty R, et al. Splenic artery aneurysm: diagnosis and endovascular therapy. J Radiol 2010; 91(11):1103–1111.

19. Sadat U, Dar O, Walsh S, Varty K. Splenic artery aneurysms in pregnancy. A systematic review. Int J Surg 2008; 6(3): 261–265. doi: 10.1016/j.ijsu.2007.08.002 17869597

20. Shovlin CL. Hereditary haemorrhagic telangiectasia: Pathophysiology, diagnosis and treatment. Blood Rev 2010; 24(6): 203–219. doi: 10.1016/j.blre.2010.07.001 20870325

21. Plauchu H, Chadarévian D, Bideau A, Robert JM. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32(3): 291–297. doi: 10.1002/ajmg.1320320302 2729347

22. Buscarini E, Leandro G, Conte D, Danesino C, Daina E, Manfredi G, et al. Natural History and Outcome of Hepatic Vascular Malformations in a Large Cohort of Patients with Hereditary Hemorrhagic Telangiectasia. Dig Dis Sci 2011; 56(7): 2166–2178. doi: 10.1007/s10620-011-1585-2 21290179

23. Abbas MA, Stone WM, Fowl RJ Gloviczki P, Oldenburg WA, Pairolero PC, et al. Splenic Artery Aneurysms: Two Decades Experience at Mayo Clinic. Ann Vasc Surg 2002; 16(4): 442–449. doi: 10.1007/s10016-001-0207-4 12089631

24. Dave SP, Reis ED, Hossain A, Taub PJ, Kerstein MD, Hollier LH. Splenic artery aneurysm in the 1990s. Ann Vasc Surg 2000; 14(3): 223–229. doi: 10.1007/s100169910039 10796953

25. Mattar SG, Lumsden AB. The management of splenic artery aneurysms: experience with 23 cases. Am J Surg 1995; 169(6): 580–584. doi: 10.1016/s0002-9610(99)80225-6 7771620

26. Trastek VF, Pairolero PC, Joyce JW, Hollier LH, Bernatz PE. Splenic artery aneurysms. Surgery 1982; 91(6): 694–699. 7079972

27. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004; 363(9412): 852–859. doi: 10.1016/S0140-6736(04)15732-2 15031030

28. Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 2009; 46(2): 119–137. doi: 10.1159/000151766 18765947

29. Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, et al. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 2006; 140(5): 463–470 doi: 10.1002/ajmg.a.31101 16470787

Článek vyšel v časopise


2020 Číslo 1